Global Soft Capsules Drugs Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Soft gel capsules are typically a gelatin-based shell, containing a liquid. They can be used as a dosage form for a variety of medicines, including complementary medicines, such as vitamins. In some cases, these medicines may have directions for use that say that they can or should be chewed.
LPI (LP Information)' newest research report, the “Soft Capsules Drugs Industry Forecast” looks at past sales and reviews total world Soft Capsules Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Soft Capsules Drugs sales for 2023 through 2029. With Soft Capsules Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Soft Capsules Drugs industry.
This Insight Report provides a comprehensive analysis of the global Soft Capsules Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Soft Capsules Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Soft Capsules Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Soft Capsules Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Soft Capsules Drugs.
The global Soft Capsules Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Soft Capsules Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Soft Capsules Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Soft Capsules Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Soft Capsules Drugs players cover GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, Novartis, Teva, Chiesi and Sumitomo Dainippon, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Soft Capsules Drugs market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Soft gel capsules are typically a gelatin-based shell, containing a liquid. They can be used as a dosage form for a variety of medicines, including complementary medicines, such as vitamins. In some cases, these medicines may have directions for use that say that they can or should be chewed.
LPI (LP Information)' newest research report, the “Soft Capsules Drugs Industry Forecast” looks at past sales and reviews total world Soft Capsules Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Soft Capsules Drugs sales for 2023 through 2029. With Soft Capsules Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Soft Capsules Drugs industry.
This Insight Report provides a comprehensive analysis of the global Soft Capsules Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Soft Capsules Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Soft Capsules Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Soft Capsules Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Soft Capsules Drugs.
The global Soft Capsules Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Soft Capsules Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Soft Capsules Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Soft Capsules Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Soft Capsules Drugs players cover GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, Novartis, Teva, Chiesi and Sumitomo Dainippon, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Soft Capsules Drugs market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Liquid Core Drugs
- Semi-solid Core Drugs
- Hospital Pharmacy
- Retail Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- AstraZeneca
- Boehringer Ingelheim
- Vertex
- Roche
- Novartis
- Teva
- Chiesi
- Sumitomo Dainippon
- Merck
- Atrium Innovations
- Abbott
- Blackmores
- The Clorox Company
- Nature Made
- By-health
- A&Z Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Soft Capsules Drugs Market Size 2018-2029
2.1.2 Soft Capsules Drugs Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Soft Capsules Drugs Segment by Type
2.2.1 Liquid Core Drugs
2.2.2 Semi-solid Core Drugs
2.3 Soft Capsules Drugs Market Size by Type
2.3.1 Soft Capsules Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Soft Capsules Drugs Market Size Market Share by Type (2018-2023)
2.4 Soft Capsules Drugs Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.5 Soft Capsules Drugs Market Size by Application
2.5.1 Soft Capsules Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Soft Capsules Drugs Market Size Market Share by Application (2018-2023)
3 SOFT CAPSULES DRUGS MARKET SIZE BY PLAYER
3.1 Soft Capsules Drugs Market Size Market Share by Players
3.1.1 Global Soft Capsules Drugs Revenue by Players (2018-2023)
3.1.2 Global Soft Capsules Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Soft Capsules Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SOFT CAPSULES DRUGS BY REGIONS
4.1 Soft Capsules Drugs Market Size by Regions (2018-2023)
4.2 Americas Soft Capsules Drugs Market Size Growth (2018-2023)
4.3 APAC Soft Capsules Drugs Market Size Growth (2018-2023)
4.4 Europe Soft Capsules Drugs Market Size Growth (2018-2023)
4.5 Middle East & Africa Soft Capsules Drugs Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Soft Capsules Drugs Market Size by Country (2018-2023)
5.2 Americas Soft Capsules Drugs Market Size by Type (2018-2023)
5.3 Americas Soft Capsules Drugs Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Soft Capsules Drugs Market Size by Region (2018-2023)
6.2 APAC Soft Capsules Drugs Market Size by Type (2018-2023)
6.3 APAC Soft Capsules Drugs Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Soft Capsules Drugs by Country (2018-2023)
7.2 Europe Soft Capsules Drugs Market Size by Type (2018-2023)
7.3 Europe Soft Capsules Drugs Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Soft Capsules Drugs by Region (2018-2023)
8.2 Middle East & Africa Soft Capsules Drugs Market Size by Type (2018-2023)
8.3 Middle East & Africa Soft Capsules Drugs Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SOFT CAPSULES DRUGS MARKET FORECAST
10.1 Global Soft Capsules Drugs Forecast by Regions (2024-2029)
10.1.1 Global Soft Capsules Drugs Forecast by Regions (2024-2029)
10.1.2 Americas Soft Capsules Drugs Forecast
10.1.3 APAC Soft Capsules Drugs Forecast
10.1.4 Europe Soft Capsules Drugs Forecast
10.1.5 Middle East & Africa Soft Capsules Drugs Forecast
10.2 Americas Soft Capsules Drugs Forecast by Country (2024-2029)
10.2.1 United States Soft Capsules Drugs Market Forecast
10.2.2 Canada Soft Capsules Drugs Market Forecast
10.2.3 Mexico Soft Capsules Drugs Market Forecast
10.2.4 Brazil Soft Capsules Drugs Market Forecast
10.3 APAC Soft Capsules Drugs Forecast by Region (2024-2029)
10.3.1 China Soft Capsules Drugs Market Forecast
10.3.2 Japan Soft Capsules Drugs Market Forecast
10.3.3 Korea Soft Capsules Drugs Market Forecast
10.3.4 Southeast Asia Soft Capsules Drugs Market Forecast
10.3.5 India Soft Capsules Drugs Market Forecast
10.3.6 Australia Soft Capsules Drugs Market Forecast
10.4 Europe Soft Capsules Drugs Forecast by Country (2024-2029)
10.4.1 Germany Soft Capsules Drugs Market Forecast
10.4.2 France Soft Capsules Drugs Market Forecast
10.4.3 UK Soft Capsules Drugs Market Forecast
10.4.4 Italy Soft Capsules Drugs Market Forecast
10.4.5 Russia Soft Capsules Drugs Market Forecast
10.5 Middle East & Africa Soft Capsules Drugs Forecast by Region (2024-2029)
10.5.1 Egypt Soft Capsules Drugs Market Forecast
10.5.2 South Africa Soft Capsules Drugs Market Forecast
10.5.3 Israel Soft Capsules Drugs Market Forecast
10.5.4 Turkey Soft Capsules Drugs Market Forecast
10.5.5 GCC Countries Soft Capsules Drugs Market Forecast
10.6 Global Soft Capsules Drugs Forecast by Type (2024-2029)
10.7 Global Soft Capsules Drugs Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Soft Capsules Drugs Product Offered
11.1.3 GSK Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 GSK Main Business Overview
11.1.5 GSK Latest Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Soft Capsules Drugs Product Offered
11.2.3 AstraZeneca Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 AstraZeneca Main Business Overview
11.2.5 AstraZeneca Latest Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Soft Capsules Drugs Product Offered
11.3.3 Boehringer Ingelheim Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Boehringer Ingelheim Main Business Overview
11.3.5 Boehringer Ingelheim Latest Developments
11.4 Vertex
11.4.1 Vertex Company Information
11.4.2 Vertex Soft Capsules Drugs Product Offered
11.4.3 Vertex Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Vertex Main Business Overview
11.4.5 Vertex Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Soft Capsules Drugs Product Offered
11.5.3 Roche Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Soft Capsules Drugs Product Offered
11.6.3 Novartis Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Teva
11.7.1 Teva Company Information
11.7.2 Teva Soft Capsules Drugs Product Offered
11.7.3 Teva Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Teva Main Business Overview
11.7.5 Teva Latest Developments
11.8 Chiesi
11.8.1 Chiesi Company Information
11.8.2 Chiesi Soft Capsules Drugs Product Offered
11.8.3 Chiesi Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Chiesi Main Business Overview
11.8.5 Chiesi Latest Developments
11.9 Sumitomo Dainippon
11.9.1 Sumitomo Dainippon Company Information
11.9.2 Sumitomo Dainippon Soft Capsules Drugs Product Offered
11.9.3 Sumitomo Dainippon Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Sumitomo Dainippon Main Business Overview
11.9.5 Sumitomo Dainippon Latest Developments
11.10 Merck
11.10.1 Merck Company Information
11.10.2 Merck Soft Capsules Drugs Product Offered
11.10.3 Merck Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Merck Main Business Overview
11.10.5 Merck Latest Developments
11.11 Atrium Innovations
11.11.1 Atrium Innovations Company Information
11.11.2 Atrium Innovations Soft Capsules Drugs Product Offered
11.11.3 Atrium Innovations Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Atrium Innovations Main Business Overview
11.11.5 Atrium Innovations Latest Developments
11.12 Abbott
11.12.1 Abbott Company Information
11.12.2 Abbott Soft Capsules Drugs Product Offered
11.12.3 Abbott Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Abbott Main Business Overview
11.12.5 Abbott Latest Developments
11.13 Blackmores
11.13.1 Blackmores Company Information
11.13.2 Blackmores Soft Capsules Drugs Product Offered
11.13.3 Blackmores Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Blackmores Main Business Overview
11.13.5 Blackmores Latest Developments
11.14 The Clorox Company
11.14.1 The Clorox Company Company Information
11.14.2 The Clorox Company Soft Capsules Drugs Product Offered
11.14.3 The Clorox Company Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 The Clorox Company Main Business Overview
11.14.5 The Clorox Company Latest Developments
11.15 Nature Made
11.15.1 Nature Made Company Information
11.15.2 Nature Made Soft Capsules Drugs Product Offered
11.15.3 Nature Made Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Nature Made Main Business Overview
11.15.5 Nature Made Latest Developments
11.16 By-health
11.16.1 By-health Company Information
11.16.2 By-health Soft Capsules Drugs Product Offered
11.16.3 By-health Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 By-health Main Business Overview
11.16.5 By-health Latest Developments
11.17 A&Z Pharmaceutical
11.17.1 A&Z Pharmaceutical Company Information
11.17.2 A&Z Pharmaceutical Soft Capsules Drugs Product Offered
11.17.3 A&Z Pharmaceutical Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 A&Z Pharmaceutical Main Business Overview
11.17.5 A&Z Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Soft Capsules Drugs Market Size 2018-2029
2.1.2 Soft Capsules Drugs Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Soft Capsules Drugs Segment by Type
2.2.1 Liquid Core Drugs
2.2.2 Semi-solid Core Drugs
2.3 Soft Capsules Drugs Market Size by Type
2.3.1 Soft Capsules Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Soft Capsules Drugs Market Size Market Share by Type (2018-2023)
2.4 Soft Capsules Drugs Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.5 Soft Capsules Drugs Market Size by Application
2.5.1 Soft Capsules Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Soft Capsules Drugs Market Size Market Share by Application (2018-2023)
3 SOFT CAPSULES DRUGS MARKET SIZE BY PLAYER
3.1 Soft Capsules Drugs Market Size Market Share by Players
3.1.1 Global Soft Capsules Drugs Revenue by Players (2018-2023)
3.1.2 Global Soft Capsules Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Soft Capsules Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SOFT CAPSULES DRUGS BY REGIONS
4.1 Soft Capsules Drugs Market Size by Regions (2018-2023)
4.2 Americas Soft Capsules Drugs Market Size Growth (2018-2023)
4.3 APAC Soft Capsules Drugs Market Size Growth (2018-2023)
4.4 Europe Soft Capsules Drugs Market Size Growth (2018-2023)
4.5 Middle East & Africa Soft Capsules Drugs Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Soft Capsules Drugs Market Size by Country (2018-2023)
5.2 Americas Soft Capsules Drugs Market Size by Type (2018-2023)
5.3 Americas Soft Capsules Drugs Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Soft Capsules Drugs Market Size by Region (2018-2023)
6.2 APAC Soft Capsules Drugs Market Size by Type (2018-2023)
6.3 APAC Soft Capsules Drugs Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Soft Capsules Drugs by Country (2018-2023)
7.2 Europe Soft Capsules Drugs Market Size by Type (2018-2023)
7.3 Europe Soft Capsules Drugs Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Soft Capsules Drugs by Region (2018-2023)
8.2 Middle East & Africa Soft Capsules Drugs Market Size by Type (2018-2023)
8.3 Middle East & Africa Soft Capsules Drugs Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SOFT CAPSULES DRUGS MARKET FORECAST
10.1 Global Soft Capsules Drugs Forecast by Regions (2024-2029)
10.1.1 Global Soft Capsules Drugs Forecast by Regions (2024-2029)
10.1.2 Americas Soft Capsules Drugs Forecast
10.1.3 APAC Soft Capsules Drugs Forecast
10.1.4 Europe Soft Capsules Drugs Forecast
10.1.5 Middle East & Africa Soft Capsules Drugs Forecast
10.2 Americas Soft Capsules Drugs Forecast by Country (2024-2029)
10.2.1 United States Soft Capsules Drugs Market Forecast
10.2.2 Canada Soft Capsules Drugs Market Forecast
10.2.3 Mexico Soft Capsules Drugs Market Forecast
10.2.4 Brazil Soft Capsules Drugs Market Forecast
10.3 APAC Soft Capsules Drugs Forecast by Region (2024-2029)
10.3.1 China Soft Capsules Drugs Market Forecast
10.3.2 Japan Soft Capsules Drugs Market Forecast
10.3.3 Korea Soft Capsules Drugs Market Forecast
10.3.4 Southeast Asia Soft Capsules Drugs Market Forecast
10.3.5 India Soft Capsules Drugs Market Forecast
10.3.6 Australia Soft Capsules Drugs Market Forecast
10.4 Europe Soft Capsules Drugs Forecast by Country (2024-2029)
10.4.1 Germany Soft Capsules Drugs Market Forecast
10.4.2 France Soft Capsules Drugs Market Forecast
10.4.3 UK Soft Capsules Drugs Market Forecast
10.4.4 Italy Soft Capsules Drugs Market Forecast
10.4.5 Russia Soft Capsules Drugs Market Forecast
10.5 Middle East & Africa Soft Capsules Drugs Forecast by Region (2024-2029)
10.5.1 Egypt Soft Capsules Drugs Market Forecast
10.5.2 South Africa Soft Capsules Drugs Market Forecast
10.5.3 Israel Soft Capsules Drugs Market Forecast
10.5.4 Turkey Soft Capsules Drugs Market Forecast
10.5.5 GCC Countries Soft Capsules Drugs Market Forecast
10.6 Global Soft Capsules Drugs Forecast by Type (2024-2029)
10.7 Global Soft Capsules Drugs Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Soft Capsules Drugs Product Offered
11.1.3 GSK Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 GSK Main Business Overview
11.1.5 GSK Latest Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Soft Capsules Drugs Product Offered
11.2.3 AstraZeneca Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 AstraZeneca Main Business Overview
11.2.5 AstraZeneca Latest Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Soft Capsules Drugs Product Offered
11.3.3 Boehringer Ingelheim Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Boehringer Ingelheim Main Business Overview
11.3.5 Boehringer Ingelheim Latest Developments
11.4 Vertex
11.4.1 Vertex Company Information
11.4.2 Vertex Soft Capsules Drugs Product Offered
11.4.3 Vertex Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Vertex Main Business Overview
11.4.5 Vertex Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Soft Capsules Drugs Product Offered
11.5.3 Roche Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Soft Capsules Drugs Product Offered
11.6.3 Novartis Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Teva
11.7.1 Teva Company Information
11.7.2 Teva Soft Capsules Drugs Product Offered
11.7.3 Teva Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Teva Main Business Overview
11.7.5 Teva Latest Developments
11.8 Chiesi
11.8.1 Chiesi Company Information
11.8.2 Chiesi Soft Capsules Drugs Product Offered
11.8.3 Chiesi Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Chiesi Main Business Overview
11.8.5 Chiesi Latest Developments
11.9 Sumitomo Dainippon
11.9.1 Sumitomo Dainippon Company Information
11.9.2 Sumitomo Dainippon Soft Capsules Drugs Product Offered
11.9.3 Sumitomo Dainippon Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Sumitomo Dainippon Main Business Overview
11.9.5 Sumitomo Dainippon Latest Developments
11.10 Merck
11.10.1 Merck Company Information
11.10.2 Merck Soft Capsules Drugs Product Offered
11.10.3 Merck Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Merck Main Business Overview
11.10.5 Merck Latest Developments
11.11 Atrium Innovations
11.11.1 Atrium Innovations Company Information
11.11.2 Atrium Innovations Soft Capsules Drugs Product Offered
11.11.3 Atrium Innovations Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Atrium Innovations Main Business Overview
11.11.5 Atrium Innovations Latest Developments
11.12 Abbott
11.12.1 Abbott Company Information
11.12.2 Abbott Soft Capsules Drugs Product Offered
11.12.3 Abbott Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Abbott Main Business Overview
11.12.5 Abbott Latest Developments
11.13 Blackmores
11.13.1 Blackmores Company Information
11.13.2 Blackmores Soft Capsules Drugs Product Offered
11.13.3 Blackmores Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Blackmores Main Business Overview
11.13.5 Blackmores Latest Developments
11.14 The Clorox Company
11.14.1 The Clorox Company Company Information
11.14.2 The Clorox Company Soft Capsules Drugs Product Offered
11.14.3 The Clorox Company Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 The Clorox Company Main Business Overview
11.14.5 The Clorox Company Latest Developments
11.15 Nature Made
11.15.1 Nature Made Company Information
11.15.2 Nature Made Soft Capsules Drugs Product Offered
11.15.3 Nature Made Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Nature Made Main Business Overview
11.15.5 Nature Made Latest Developments
11.16 By-health
11.16.1 By-health Company Information
11.16.2 By-health Soft Capsules Drugs Product Offered
11.16.3 By-health Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 By-health Main Business Overview
11.16.5 By-health Latest Developments
11.17 A&Z Pharmaceutical
11.17.1 A&Z Pharmaceutical Company Information
11.17.2 A&Z Pharmaceutical Soft Capsules Drugs Product Offered
11.17.3 A&Z Pharmaceutical Soft Capsules Drugs Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 A&Z Pharmaceutical Main Business Overview
11.17.5 A&Z Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Soft Capsules Drugs Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Liquid Core Drugs
Table 3. Major Players of Semi-solid Core Drugs
Table 4. Soft Capsules Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Soft Capsules Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Soft Capsules Drugs Market Size Market Share by Type (2018-2023)
Table 7. Soft Capsules Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Soft Capsules Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Soft Capsules Drugs Market Size Market Share by Application (2018-2023)
Table 10. Global Soft Capsules Drugs Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Soft Capsules Drugs Revenue Market Share by Player (2018-2023)
Table 12. Soft Capsules Drugs Key Players Head office and Products Offered
Table 13. Soft Capsules Drugs Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Soft Capsules Drugs Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Soft Capsules Drugs Market Size Market Share by Regions (2018-2023)
Table 18. Global Soft Capsules Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Soft Capsules Drugs Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Soft Capsules Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Soft Capsules Drugs Market Size Market Share by Country (2018-2023)
Table 22. Americas Soft Capsules Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Soft Capsules Drugs Market Size Market Share by Type (2018-2023)
Table 24. Americas Soft Capsules Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Soft Capsules Drugs Market Size Market Share by Application (2018-2023)
Table 26. APAC Soft Capsules Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Soft Capsules Drugs Market Size Market Share by Region (2018-2023)
Table 28. APAC Soft Capsules Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Soft Capsules Drugs Market Size Market Share by Type (2018-2023)
Table 30. APAC Soft Capsules Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Soft Capsules Drugs Market Size Market Share by Application (2018-2023)
Table 32. Europe Soft Capsules Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Soft Capsules Drugs Market Size Market Share by Country (2018-2023)
Table 34. Europe Soft Capsules Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Soft Capsules Drugs Market Size Market Share by Type (2018-2023)
Table 36. Europe Soft Capsules Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Soft Capsules Drugs Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Soft Capsules Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Soft Capsules Drugs Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Soft Capsules Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Soft Capsules Drugs Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Soft Capsules Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Soft Capsules Drugs Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Soft Capsules Drugs
Table 45. Key Market Challenges & Risks of Soft Capsules Drugs
Table 46. Key Industry Trends of Soft Capsules Drugs
Table 47. Global Soft Capsules Drugs Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Soft Capsules Drugs Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Soft Capsules Drugs Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Soft Capsules Drugs Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. GSK Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 52. GSK Soft Capsules Drugs Product Offered
Table 53. GSK Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. GSK Main Business
Table 55. GSK Latest Developments
Table 56. AstraZeneca Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 57. AstraZeneca Soft Capsules Drugs Product Offered
Table 58. AstraZeneca Main Business
Table 59. AstraZeneca Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. AstraZeneca Latest Developments
Table 61. Boehringer Ingelheim Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 62. Boehringer Ingelheim Soft Capsules Drugs Product Offered
Table 63. Boehringer Ingelheim Main Business
Table 64. Boehringer Ingelheim Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Boehringer Ingelheim Latest Developments
Table 66. Vertex Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 67. Vertex Soft Capsules Drugs Product Offered
Table 68. Vertex Main Business
Table 69. Vertex Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Vertex Latest Developments
Table 71. Roche Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 72. Roche Soft Capsules Drugs Product Offered
Table 73. Roche Main Business
Table 74. Roche Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Roche Latest Developments
Table 76. Novartis Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 77. Novartis Soft Capsules Drugs Product Offered
Table 78. Novartis Main Business
Table 79. Novartis Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Novartis Latest Developments
Table 81. Teva Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 82. Teva Soft Capsules Drugs Product Offered
Table 83. Teva Main Business
Table 84. Teva Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Teva Latest Developments
Table 86. Chiesi Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 87. Chiesi Soft Capsules Drugs Product Offered
Table 88. Chiesi Main Business
Table 89. Chiesi Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Chiesi Latest Developments
Table 91. Sumitomo Dainippon Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 92. Sumitomo Dainippon Soft Capsules Drugs Product Offered
Table 93. Sumitomo Dainippon Main Business
Table 94. Sumitomo Dainippon Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Sumitomo Dainippon Latest Developments
Table 96. Merck Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 97. Merck Soft Capsules Drugs Product Offered
Table 98. Merck Main Business
Table 99. Merck Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Merck Latest Developments
Table 101. Atrium Innovations Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 102. Atrium Innovations Soft Capsules Drugs Product Offered
Table 103. Atrium Innovations Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Atrium Innovations Main Business
Table 105. Atrium Innovations Latest Developments
Table 106. Abbott Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 107. Abbott Soft Capsules Drugs Product Offered
Table 108. Abbott Main Business
Table 109. Abbott Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Abbott Latest Developments
Table 111. Blackmores Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 112. Blackmores Soft Capsules Drugs Product Offered
Table 113. Blackmores Main Business
Table 114. Blackmores Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Blackmores Latest Developments
Table 116. The Clorox Company Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 117. The Clorox Company Soft Capsules Drugs Product Offered
Table 118. The Clorox Company Main Business
Table 119. The Clorox Company Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. The Clorox Company Latest Developments
Table 121. Nature Made Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 122. Nature Made Soft Capsules Drugs Product Offered
Table 123. Nature Made Main Business
Table 124. Nature Made Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Nature Made Latest Developments
Table 126. By-health Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 127. By-health Soft Capsules Drugs Product Offered
Table 128. By-health Main Business
Table 129. By-health Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. By-health Latest Developments
Table 131. A&Z Pharmaceutical Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 132. A&Z Pharmaceutical Soft Capsules Drugs Product Offered
Table 133. A&Z Pharmaceutical Main Business
Table 134. A&Z Pharmaceutical Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. A&Z Pharmaceutical Latest Developments
Table 1. Soft Capsules Drugs Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Liquid Core Drugs
Table 3. Major Players of Semi-solid Core Drugs
Table 4. Soft Capsules Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Soft Capsules Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Soft Capsules Drugs Market Size Market Share by Type (2018-2023)
Table 7. Soft Capsules Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Soft Capsules Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Soft Capsules Drugs Market Size Market Share by Application (2018-2023)
Table 10. Global Soft Capsules Drugs Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Soft Capsules Drugs Revenue Market Share by Player (2018-2023)
Table 12. Soft Capsules Drugs Key Players Head office and Products Offered
Table 13. Soft Capsules Drugs Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Soft Capsules Drugs Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Soft Capsules Drugs Market Size Market Share by Regions (2018-2023)
Table 18. Global Soft Capsules Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Soft Capsules Drugs Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Soft Capsules Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Soft Capsules Drugs Market Size Market Share by Country (2018-2023)
Table 22. Americas Soft Capsules Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Soft Capsules Drugs Market Size Market Share by Type (2018-2023)
Table 24. Americas Soft Capsules Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Soft Capsules Drugs Market Size Market Share by Application (2018-2023)
Table 26. APAC Soft Capsules Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Soft Capsules Drugs Market Size Market Share by Region (2018-2023)
Table 28. APAC Soft Capsules Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Soft Capsules Drugs Market Size Market Share by Type (2018-2023)
Table 30. APAC Soft Capsules Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Soft Capsules Drugs Market Size Market Share by Application (2018-2023)
Table 32. Europe Soft Capsules Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Soft Capsules Drugs Market Size Market Share by Country (2018-2023)
Table 34. Europe Soft Capsules Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Soft Capsules Drugs Market Size Market Share by Type (2018-2023)
Table 36. Europe Soft Capsules Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Soft Capsules Drugs Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Soft Capsules Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Soft Capsules Drugs Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Soft Capsules Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Soft Capsules Drugs Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Soft Capsules Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Soft Capsules Drugs Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Soft Capsules Drugs
Table 45. Key Market Challenges & Risks of Soft Capsules Drugs
Table 46. Key Industry Trends of Soft Capsules Drugs
Table 47. Global Soft Capsules Drugs Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Soft Capsules Drugs Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Soft Capsules Drugs Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Soft Capsules Drugs Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. GSK Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 52. GSK Soft Capsules Drugs Product Offered
Table 53. GSK Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. GSK Main Business
Table 55. GSK Latest Developments
Table 56. AstraZeneca Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 57. AstraZeneca Soft Capsules Drugs Product Offered
Table 58. AstraZeneca Main Business
Table 59. AstraZeneca Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. AstraZeneca Latest Developments
Table 61. Boehringer Ingelheim Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 62. Boehringer Ingelheim Soft Capsules Drugs Product Offered
Table 63. Boehringer Ingelheim Main Business
Table 64. Boehringer Ingelheim Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Boehringer Ingelheim Latest Developments
Table 66. Vertex Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 67. Vertex Soft Capsules Drugs Product Offered
Table 68. Vertex Main Business
Table 69. Vertex Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Vertex Latest Developments
Table 71. Roche Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 72. Roche Soft Capsules Drugs Product Offered
Table 73. Roche Main Business
Table 74. Roche Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Roche Latest Developments
Table 76. Novartis Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 77. Novartis Soft Capsules Drugs Product Offered
Table 78. Novartis Main Business
Table 79. Novartis Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Novartis Latest Developments
Table 81. Teva Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 82. Teva Soft Capsules Drugs Product Offered
Table 83. Teva Main Business
Table 84. Teva Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Teva Latest Developments
Table 86. Chiesi Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 87. Chiesi Soft Capsules Drugs Product Offered
Table 88. Chiesi Main Business
Table 89. Chiesi Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Chiesi Latest Developments
Table 91. Sumitomo Dainippon Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 92. Sumitomo Dainippon Soft Capsules Drugs Product Offered
Table 93. Sumitomo Dainippon Main Business
Table 94. Sumitomo Dainippon Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Sumitomo Dainippon Latest Developments
Table 96. Merck Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 97. Merck Soft Capsules Drugs Product Offered
Table 98. Merck Main Business
Table 99. Merck Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Merck Latest Developments
Table 101. Atrium Innovations Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 102. Atrium Innovations Soft Capsules Drugs Product Offered
Table 103. Atrium Innovations Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Atrium Innovations Main Business
Table 105. Atrium Innovations Latest Developments
Table 106. Abbott Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 107. Abbott Soft Capsules Drugs Product Offered
Table 108. Abbott Main Business
Table 109. Abbott Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Abbott Latest Developments
Table 111. Blackmores Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 112. Blackmores Soft Capsules Drugs Product Offered
Table 113. Blackmores Main Business
Table 114. Blackmores Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Blackmores Latest Developments
Table 116. The Clorox Company Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 117. The Clorox Company Soft Capsules Drugs Product Offered
Table 118. The Clorox Company Main Business
Table 119. The Clorox Company Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. The Clorox Company Latest Developments
Table 121. Nature Made Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 122. Nature Made Soft Capsules Drugs Product Offered
Table 123. Nature Made Main Business
Table 124. Nature Made Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Nature Made Latest Developments
Table 126. By-health Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 127. By-health Soft Capsules Drugs Product Offered
Table 128. By-health Main Business
Table 129. By-health Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. By-health Latest Developments
Table 131. A&Z Pharmaceutical Details, Company Type, Soft Capsules Drugs Area Served and Its Competitors
Table 132. A&Z Pharmaceutical Soft Capsules Drugs Product Offered
Table 133. A&Z Pharmaceutical Main Business
Table 134. A&Z Pharmaceutical Soft Capsules Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. A&Z Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Soft Capsules Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Soft Capsules Drugs Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Soft Capsules Drugs Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Soft Capsules Drugs Sales Market Share by Country/Region (2022)
Figure 8. Soft Capsules Drugs Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Soft Capsules Drugs Market Size Market Share by Type in 2022
Figure 10. Soft Capsules Drugs in Hospital Pharmacy
Figure 11. Global Soft Capsules Drugs Market: Hospital Pharmacy (2018-2023) & ($ Millions)
Figure 12. Soft Capsules Drugs in Retail Pharmacy
Figure 13. Global Soft Capsules Drugs Market: Retail Pharmacy (2018-2023) & ($ Millions)
Figure 14. Global Soft Capsules Drugs Market Size Market Share by Application in 2022
Figure 15. Global Soft Capsules Drugs Revenue Market Share by Player in 2022
Figure 16. Global Soft Capsules Drugs Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Soft Capsules Drugs Market Size 2018-2023 ($ Millions)
Figure 18. APAC Soft Capsules Drugs Market Size 2018-2023 ($ Millions)
Figure 19. Europe Soft Capsules Drugs Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Soft Capsules Drugs Market Size 2018-2023 ($ Millions)
Figure 21. Americas Soft Capsules Drugs Value Market Share by Country in 2022
Figure 22. United States Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Soft Capsules Drugs Market Size Market Share by Region in 2022
Figure 27. APAC Soft Capsules Drugs Market Size Market Share by Type in 2022
Figure 28. APAC Soft Capsules Drugs Market Size Market Share by Application in 2022
Figure 29. China Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Soft Capsules Drugs Market Size Market Share by Country in 2022
Figure 36. Europe Soft Capsules Drugs Market Size Market Share by Type (2018-2023)
Figure 37. Europe Soft Capsules Drugs Market Size Market Share by Application (2018-2023)
Figure 38. Germany Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Soft Capsules Drugs Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Soft Capsules Drugs Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Soft Capsules Drugs Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 52. APAC Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 53. Europe Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 55. United States Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 56. Canada Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 59. China Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 60. Japan Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 61. Korea Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 63. India Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 64. Australia Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 65. Germany Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 66. France Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 67. UK Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 68. Italy Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 69. Russia Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 70. Spain Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 73. Israel Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 76. Global Soft Capsules Drugs Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Soft Capsules Drugs Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Soft Capsules Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Soft Capsules Drugs Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Soft Capsules Drugs Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Soft Capsules Drugs Sales Market Share by Country/Region (2022)
Figure 8. Soft Capsules Drugs Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Soft Capsules Drugs Market Size Market Share by Type in 2022
Figure 10. Soft Capsules Drugs in Hospital Pharmacy
Figure 11. Global Soft Capsules Drugs Market: Hospital Pharmacy (2018-2023) & ($ Millions)
Figure 12. Soft Capsules Drugs in Retail Pharmacy
Figure 13. Global Soft Capsules Drugs Market: Retail Pharmacy (2018-2023) & ($ Millions)
Figure 14. Global Soft Capsules Drugs Market Size Market Share by Application in 2022
Figure 15. Global Soft Capsules Drugs Revenue Market Share by Player in 2022
Figure 16. Global Soft Capsules Drugs Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Soft Capsules Drugs Market Size 2018-2023 ($ Millions)
Figure 18. APAC Soft Capsules Drugs Market Size 2018-2023 ($ Millions)
Figure 19. Europe Soft Capsules Drugs Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Soft Capsules Drugs Market Size 2018-2023 ($ Millions)
Figure 21. Americas Soft Capsules Drugs Value Market Share by Country in 2022
Figure 22. United States Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Soft Capsules Drugs Market Size Market Share by Region in 2022
Figure 27. APAC Soft Capsules Drugs Market Size Market Share by Type in 2022
Figure 28. APAC Soft Capsules Drugs Market Size Market Share by Application in 2022
Figure 29. China Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Soft Capsules Drugs Market Size Market Share by Country in 2022
Figure 36. Europe Soft Capsules Drugs Market Size Market Share by Type (2018-2023)
Figure 37. Europe Soft Capsules Drugs Market Size Market Share by Application (2018-2023)
Figure 38. Germany Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Soft Capsules Drugs Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Soft Capsules Drugs Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Soft Capsules Drugs Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Soft Capsules Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 52. APAC Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 53. Europe Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 55. United States Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 56. Canada Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 59. China Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 60. Japan Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 61. Korea Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 63. India Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 64. Australia Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 65. Germany Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 66. France Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 67. UK Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 68. Italy Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 69. Russia Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 70. Spain Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 73. Israel Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Soft Capsules Drugs Market Size 2024-2029 ($ Millions)
Figure 76. Global Soft Capsules Drugs Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Soft Capsules Drugs Market Size Market Share Forecast by Application (2024-2029)
